How much? Pfizer leads top pharma companies' ramped up lobby spending on Congress
K Street saw another record year in 2021 for lobbying expenditures, and some of the biggest biopharma companies in the world shelled out millions to sway Congress, revealing some of their key priorities along the way.
Pfizer topped the list of the largest pharma companies in the latest quarter, spending nearly $3 million on lobbying in Q4, which is about half a million more than they spent in the same quarter a year earlier, but not quite as high as its Q1 2020 level of more than $4 million. In 2021, Pfizer spent more than $10.3 million, about half a million less than in 2020.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
